Literature DB >> 15451423

ATR-dependent phosphorylation of ATRIP in response to genotoxic stress.

Eisuke Itakura1, Kazuyuki Umeda, Ei Sekoguchi, Hideki Takata, Mariko Ohsumi, Akira Matsuura.   

Abstract

PI-kinase-related protein kinase ATR forms a complex with ATRIP and plays pivotal roles in maintaining genome integrity. When DNA is damaged, the ATR-ATRIP complex is recruited to chromatin and is activated to transduce the checkpoint signal, but the precise kinase activation mechanism remains unknown. Here, we show that ATRIP is phosphorylated in an ATR-dependent manner after genotoxic stimuli. The serine 68 and 72 residues are important for the phosphorylation in vivo and are required exclusively for direct modification by ATR in vitro. Using phospho-specific antibody, we demonstrated that phosphorylated ATRIP accumulates at foci induced by DNA damage. Moreover, the loss of phosphorylation does not lead to detectable changes in the relocalization of ATRIP to nuclear foci nor in the activation of downstream effector proteins. Collectively, our results suggest that the ATR-mediated phosphorylation of ATRIP at Ser-68 and -72 is dispensable for the initial response to DNA damage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15451423     DOI: 10.1016/j.bbrc.2004.08.228

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Herpes simplex virus type I disrupts the ATR-dependent DNA-damage response during lytic infection.

Authors:  Dianna E Wilkinson; Sandra K Weller
Journal:  J Cell Sci       Date:  2006-06-06       Impact factor: 5.285

Review 2.  ATR: an essential regulator of genome integrity.

Authors:  Karlene A Cimprich; David Cortez
Journal:  Nat Rev Mol Cell Biol       Date:  2008-07-02       Impact factor: 94.444

3.  Dimerization of the ATRIP protein through the coiled-coil motif and its implication to the maintenance of stalled replication forks.

Authors:  Eisuke Itakura; Isao Sawada; Akira Matsuura
Journal:  Mol Biol Cell       Date:  2005-09-21       Impact factor: 4.138

4.  Fanconi anemia proteins are required to prevent accumulation of replication-associated DNA double-strand breaks.

Authors:  Alexandra Sobeck; Stacie Stone; Vincenzo Costanzo; Bendert de Graaf; Tanja Reuter; Johan de Winter; Michael Wallisch; Yassmine Akkari; Susan Olson; Weidong Wang; Hans Joenje; Jan L Christian; Patrick J Lupardus; Karlene A Cimprich; Jean Gautier; Maureen E Hoatlin
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

5.  Function of a conserved checkpoint recruitment domain in ATRIP proteins.

Authors:  Heather L Ball; Mark R Ehrhardt; Daniel A Mordes; Gloria G Glick; Walter J Chazin; David Cortez
Journal:  Mol Cell Biol       Date:  2007-03-05       Impact factor: 4.272

6.  PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints.

Authors:  Xiongbin Lu; Bonnie Nannenga; Lawrence A Donehower
Journal:  Genes Dev       Date:  2005-05-03       Impact factor: 11.361

7.  ATR-dependent phosphorylation of FANCA on serine 1449 after DNA damage is important for FA pathway function.

Authors:  Natalie B Collins; James B Wilson; Thomas Bush; Andrei Thomashevski; Kate J Roberts; Nigel J Jones; Gary M Kupfer
Journal:  Blood       Date:  2008-12-24       Impact factor: 22.113

8.  A Model to Investigate Single-Strand DNA Responses in G1 Human Cells via a Telomere-Targeted, Nuclease-Deficient CRISPR-Cas9 System.

Authors:  Remco P Crefcoeur; Omar Zgheib; Thanos D Halazonetis
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

9.  A novel interplay between the Fanconi anemia core complex and ATR-ATRIP kinase during DNA cross-link repair.

Authors:  Junya Tomida; Akiko Itaya; Tomoko Shigechi; Junya Unno; Emi Uchida; Masae Ikura; Yuji Masuda; Shun Matsuda; Jun Adachi; Masahiko Kobayashi; Amom Ruhikanta Meetei; Yoshihiko Maehara; Ken-Ichi Yamamoto; Kenji Kamiya; Akira Matsuura; Tomonari Matsuda; Tsuyoshi Ikura; Masamichi Ishiai; Minoru Takata
Journal:  Nucleic Acids Res       Date:  2013-05-30       Impact factor: 16.971

Review 10.  Prospects for the Use of ATR Inhibitors to Treat Cancer.

Authors:  Jill M Wagner; Scott H Kaufmann
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.